Global collaboRAtion on CIC-DUX4, BCOR-CCN3, High-grade Undifferentiated Round Cell Sarcoma (URCS) Project

Launched by ISTITUTO ORTOPEDICO RIZZOLI · Apr 27, 2022

Keywords

ClinConnect Summary

The Global collaboRAtion on CIC-DUX4, BCOR-CCN3, High-grade Undifferentiated Round Cell Sarcoma (URCS) Project is a clinical trial aimed at studying a specific type of cancer called undifferentiated round cell sarcoma. This trial is looking to gather and review clinical information and tissue samples from patients diagnosed with this cancer, both from past cases dating back to January 1983 and from new patients. By analyzing this information, researchers hope to learn more about the disease and find better ways to treat it.

To participate in this trial, patients must have a confirmed diagnosis of undifferentiated round cell sarcoma and have information available about their clinical treatment and outcomes. Additionally, tissue samples from their tumors must be accessible for analysis. Unfortunately, patients with different diagnoses or without available clinical information cannot join the study. Those who do participate can expect to contribute valuable data that may help improve future treatment options for this rare and aggressive cancer.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with undifferentiated round cell sarcomas treated from 01 January 1983 and all new patients will be included.
• • Clinical and outcome information available.
• • Histological slides/formalin-fixed paraffin-embedded tissue tumor blocks from archive available to perform the histology analysis/frozen tissue representative of the tumor available.
• Exclusion Criteria:
• • Diagnosis different from undifferentiated round cell sarcomas
• • Patient with no clinical or outcome information available